This one-hour, journal article-based activity examines the efficacy and safety of methylphenidate (MPH) for the treatment of cocaine use disorder (CUD). Learners will explore findings from a systematic review and meta-analysis evaluating the effects of MPH on cocaine craving and use, including differences in outcomes among individuals with and without co-occurring attention-deficit/hyperactivity disorder (ADHD). The article also examines factors that may influence treatment outcomes, considerations related to the safety of MPH, and limitations in the current evidence base to inform future research and clinical practice.

This 40-minute, on-demand session from the ASAM 2026 Review Course provides an organ-organized overview of the main medical co-morbidities associated with drug use and discusses the importance of routine and preventive health care for patients with substance use disorders.

This 88-hour on-demand conference includes 75 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses substance use disorders in transplant candidates and recipients, covering evaluation approaches, multidisciplinary care, and long-term outcome strategies.

This 60-minute on-demand session from the ASAM 57th Annual Conference addresses drug smoking practices and health risks, including safe handling techniques and harm reduction interventions for clinical settings.

This 60-minute on-demand session from the ASAM 57th Annual Conference addresses alcohol use disorder treatment in patients with liver disease, including pharmacotherapy safety, transplant considerations, and integrated care models.

This 60-minute on-demand session from the ASAM 57th Annual Conference addresses collaborative care for OUD with co-occurring mental disorders, featuring new research findings and implementation guidance.

In this episode of ASAM Practice Pearls, Drs. Stephen Taylor and Smita Das discuss co-occurring psychiatric and substance use disorders (SUD). They explore the most common psychiatric conditions seen alongside addiction, share strategies for distinguishing primary psychiatric disorders from substance-induced symptoms, and review approaches to screening, treatment planning, and integrated care. The conversation highlights practical screening tools, medication considerations, and populations with unique clinical needs, emphasizing the importance of treating both conditions concurrently.

This 35-minute, on-demand session from the ASAM 2025 Review Course provides an organ-organized overview of the main medical co-morbidities associated with drug use and discusses the importance of routine and preventive health care for patients with substance use disorders.

This 75-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.